Nerve Repair and Regeneration Global Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by 2028 | DelveInsight

The global nerve repair and regeneration market is anticipated to grow in the coming years due to the factors such as the increased frequency of nerve injuries, as well as the rising prevalence of lifestyle conditions such as diabetes and hypertension. Furthermore, technological developments in the nerve repair product portfolio, as well as recent product approvals, are some of the factors contributing to the global nerve repair and regeneration market growth

LAS VEGAS, Aug. 17, 2023 /PRNewswire/ -- DelveInsight's Nerve Repair and Regeneration Market Insights report provides the current and forecast market analysis, individual leading nerve repair and regeneration companies' market shares, challenges, nerve repair and regeneration market drivers, barriers, trends, and key market nerve repair and regeneration companies in the market.

Key Takeaways from the Nerve Repair and Regeneration Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global nerve repair and regeneration market during the forecast period. 
• Notable nerve repair and regeneration companies such as Medtronic, Boston Scientific Corporation, AxoGen Inc., Baxter International, Checkpoint Surgical, Inc., Integra Lifesciences Corporation, Polyganics B.V., Orthomed S.A.S, Salumedica, LLC, Alafair Biosciences, Inc., Neurometrix, Inc., TOYOBO CO., LTD, LivaNova PLC, Synapse Biomedical, Inc., Abbott, Keri Medical, Nevro Corp., Collagen matrix, Inc., Aleva Neurotherapeutics SA, Orthocell, Ltd., and several others, are currently operating in the nerve repair and regeneration market.
• In July 2022, Pulsetto, Healthtech startup, launched a neuromodulation device that stimulates the vagus nerve. Stimulating this nerve with electric impulses activates the parasympathetic nervous system, allowing the body to rest and relax. This device can be used for nerve regeneration.
• In March 2022, Integra LifeSciences, introduced NeuraGen 3D Nerve Guide Matrix, a resorbable implant for the repair of peripheral nerve discontinuities. This product is developed to make an optimized environment, which would enable a more complete functional recovery following mid-gap nerve repair when compared to hollow nerve conduits alone.
• In January 2022, Checkpoint Surgical, Inc., the leader in intraoperative nerve repair stimulation technology, announced it has enrolled the first patient in its multi-center clinical study of the company's breakthrough nerve regeneration technology, Checkpoint BEST (Brief Electrical Stimulation Therapy) system.

To read more about the latest highlights related to the nerve repair and regeneration market, get a snapshot of the key highlights entailed in the Global Nerve Repair and Regeneration Market Report

Nerve Repair and Regeneration Overview

Nerve repair and regeneration is a complex and fascinating field within the realm of medical science. It focuses on the restoration of damaged or injured nerves, which play a crucial role in transmitting signals between the brain, spinal cord, and the rest of the body. When nerves are damaged due to trauma, disease, or other factors, it can lead to debilitating conditions and loss of sensory or motor functions. Researchers and clinicians employ a variety of innovative approaches to promote nerve regrowth and recovery. Techniques such as surgical interventions, tissue engineering, and advanced biomaterials are being developed to facilitate the reconnection of severed nerve fibers and guide their regrowth along the correct pathways. Additionally, advancements in neurobiology and regenerative medicine are shedding light on the intricate molecular and cellular mechanisms underlying nerve repair, offering hope for more effective treatments and improved outcomes for patients grappling with nerve injuries. As this field continues to evolve, it holds the potential to significantly enhance the quality of life for individuals affected by nerve damage.

Nerve Repair and Regeneration Market Insights

North America held a substantial share of 31.55% in the overall nerve repair and regeneration market in 2021, and this position is expected to be maintained from 2023 to 2028. This dominance is attributable to an increase in the number of neurological disorders, the presence of leading nerve repair and regeneration companies such as Boston Scientific Incorporation, Medtronic plc., Stryker Corporation, and Nevro Corporation, among others, excellent R&D, and regulatory guidelines, among other factors.

In addition, Europe has the world's second-largest market for nerve repair and regeneration products. This is due to recent launches and approvals for nerve repair and regeneration, an increase in nerve injuries, an increase in acquisitions and mergers, and an increase in lifestyle-related illnesses, among other factors. Cook Biotech, for example, got CE Mark clearance for Axoguard Nerve Connector and Axoguard Nerve Protector in March 2020. Furthermore, the increase in the frequency of disorders such as rheumatoid arthritis, osteoporosis, diabetes, and cancer in the region would increase the demand for nerve repair products.

To know more about why North America is leading the market growth in the nerve repair and regeneration market, get a snapshot of the Nerve Repair and Regeneration Market Outlook 

Nerve Repair and Regeneration Market Dynamics

The nerve repair and regeneration market is currently gaining traction due to the rising prevalence of lifestyle-related diseases such as diabetes and hypertension. Furthermore, rising nerve injury cases around the world are driving up demand for nerve repair and regeneration products, consequently fueling the global nerve repair and regeneration market. In addition, an increase in traumatic injuries caused by car accidents, work accidents, and falls, among other things, could result in peripheral nerve damage, increasing demand for nerve repair and regeneration products.

However, the high cost of nerve repair and regeneration products and the availability of alternative treatment approaches, are projected to stymie nerve repair and regeneration market expansion in the coming years.

Additionally, the COVID-19 pandemic has had a severe influence on the nerve repair and regeneration market. The market demand for nerve repair and regeneration products had decreased due to the temporary suspension of numerous elective procedures and outpatient visits as healthcare system guidelines around the world temporarily focused all of their efforts on managing the COVID-19 patient load during the lockdown period. Furthermore, as a result of the disruption of raw materials, supply chains, cross-border trades, manpower, and resources, the leading companies halted their manufacturing units, reducing the number of gadgets in the nerve repair and regeneration market.

However, due to the approval and administration of numerous COVID-19 vaccines around the world, as well as the recovery of all resources, there has been a significant improvement in the resumption of activities across various domains, including healthcare services, paving the way for a solid period of recovery for the nerve and regeneration market. As a result, the global market for nerve repair and regeneration products is expected to increase steadily over the forecast period.

Get a sneak peek at the nerve repair and regeneration market dynamics @ Nerve Repair and Regeneration Market Dynamics Analysis

Nerve Repair and Regeneration Market Assessment

• Nerve Repair and Regeneration Market Segmentation
• Nerve Repair and Regeneration Market Segmentation By Product Type: Biomaterials [Nerve Connectors/Conduits, Nerve Protectors, Nerve Wraps, and Nerve Graft {Autografts, Allografts, And Xenografts}] and Neuromodulation Devices [External Neuromodulation Devices {Transcutaneous Electrical Nerve Stimulation Devices and Transcranial Magnetic Stimulation Devices} and Internal Neuromodulation Devices {Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, and Others Devices}]
• Nerve Repair and Regeneration Market Segmentation By End User: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
• Nerve Repair and Regeneration Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the nerve repair and regeneration market are set to emerge as the trendsetter explore @ Nerve Repair and Regeneration Companies 

Table of Contents 

Interested in knowing the nerve repair and regeneration market by 2028? Click to get a snapshot of the Nerve Repair and Regeneration Market Trends

Related Reports

Neurostimulation Devices Market

Neurostimulation Devices Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neurostimulation devices companies, including Medtronic PLC, Cyberonics, Boston Scientific Corporation, Abbott Laboratories, Aleva Neurotherapeutic, ElectroCore Inc., EndoStim Inc., Nevro Corporation, among others.

Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key deep brain stimulation devices companies, including Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Beijing PINS Medical Co., Ltd., Aleva Neurotherapeutics SA, SceneRay Corporation, SceneRay (Suzhou) Medical Technology Co., Ltd., Functional Neuromodulation Ltd., NeuroPace, Inc., Sapiens Neuro, Aleva Neurosurgery, St. Jude Medical, Inc. (now part of Abbott Laboratories), Fisher Wallace Laboratories, Brainsway Ltd., Aleva Neurotherapeutics (USA) Inc., Zynex Medical Inc., MagVenture A/S, SceneRay-Explant, SceneRay-US, SceneRay-EU, among others. 

Neuromodulation Devices Market

Neuromodulation Devices Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neuromodulation devices companies, including Medtronic, Boston Scientific Corporation, Abbott, LivaNova, NeuroSigma, NEVRO CORP., Synapse Biomedical Inc., NeuroPace, Inc., Bioventus., Soterix Medical Inc., among others.

Neuroprosthetics Market

Neuroprosthetics Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key neuroprosthetics companies, including Medtronic, Cochlear Ltd., Abbott, Boston Scientific Corporation, LivaNova, Second Sight Medical Products, Inc., MED-EL, Retina Implant AG, Sonova, NeuroPace, Inc., among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Contact Us

Shruti Thakur
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/medical-devices 

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg